HER2-positive breast cancer with brain metastasis, long responder to lapatinib therapy
We report the case of a 45-year-old patient diagnosed, after four years from the initial diagnosis of infiltrating ductal carcinoma, with lymph node, hepatic, pulmonary and bone diseases deriving from HER2-positive breast cancer. While the association docetaxel + trastuzumab led to a partial respons...
| Κύριος συγγραφέας: | |
|---|---|
| Μορφή: | Άρθρο |
| Γλώσσα: | English |
| Έκδοση: |
AboutScience Srl
2018-06-01
|
| Σειρά: | AboutOpen |
| Θέματα: | |
| Διαθέσιμο Online: | https://journals.aboutscience.eu/index.php/aboutopen/article/view/160 |